THURSDAY JANUARY 24 Joint Models |
|
10.00 am |
Coffee and registration |
10.30 am |
♦ Introduction to joint models - Michael Sweeting (George Davies Centre, University of Leicester, England) |
11.05 am |
♦ Joint models for longitudinal marker and multivariate survival data - Loïc Ferrer (Institut Curie, Inserm U900, Paris) |
11.40 am |
♦ Recent advances in joint models for multivariate longitudinal data and event-times with application to cancer - Ruwanthi Kolamunnage-Dona (Institute of Translational Medicine, Department of Biostatistics, University of Liverpool, England) |
12.15 am |
Lunch break |
1.45 pm |
♦ Joint analysis of health-related quality of life and time to progression/time to dropout in cancer clinical trials - Célia Touraine (Montpellier Cancer Institute , Biometry Unit, Montpellier) |
2.20 pm |
♦ Joint latent class model for multivariate longitudinal data and survival data: heterogeneous trajectories of tiredness in metastatic colorectal cancer - Cécile Proust-Lima (Inserm U1219 " Bordeaux Population Health", Bordeaux) |
2.55 pm |
♦ Personalized screening intervals for biomarkers using joint models for longitudinal and survival data - Dimitris Rizopoulos (Erasmus University Medical Center, Rotterdam, the Netherlands) Slides are available on Dimitris Rizopoulos Website
|
3.30 pm |
Coffee break |
3.50 pm |
♦ Joint models for recurrent events and a terminal event - Virginie Rondeau (Inserm U1219 "Bordeaux Population Health") |
4.25 pm |
♦ Mechanistic models in cancer research - Jérémie Guedj (Inserm, UMR 1337 "Infection, Antimicrobials, Modelling, Evolution", Paris) |
FRIDAY JANUARY 25 STATISTICAL ISSUES AND CHALLENGES WITH IMMUNOTHERAPIES |
|
8.30 am |
Coffee |
9.00 am |
♦ Introduction - Emilio Bria (U.O.C. Medical Oncology, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Roma, Italy) |
9.35 am |
♦ Immune-related response criteria - Lesley Seymour (Queen's University, Ontario, Canada) |
10.10 am |
♦ A systematic litterature review on surrogate endpoints of overall survival in patients treated with immune-checkpoint inhibitors - Sébastien Branchoux (BMS, Health Economics & Public Health, Rueil-Malmaison & Inserm U1219 "Bordeaux Population Health") |
10.45 am |
Coffee break |
11.05 am |
♦ The use of joint modeling to analyze tumor dynamic and immunotherapies - Denis Rustand (Inserm U1219 " Bordeaux population Health") |
11.40 am |
♦ Mathematical models for cancer immunotherapy, review and new directions - Anna Konstorum (Uconn Health, Center for Quantitative Medicine, Farmington, Connecticut) |
12.15 am |
End of the SMAC 2019 scientific days Lunch |